Printer Friendly

AMA OPINION: COMMEND AND SUPPORT HIV VACCINE RESEARCH

       AMA OPINION:  COMMEND AND SUPPORT HIV VACCINE RESEARCH
    CHICAGO, Feb. 21 /PRNewswire/ -- The following statement is attributable to M. Roy Schwarz, M.D., senior vice president, American Medical Association:
    "The American Medical Association is delighted with the research findings published recently in Nature which point to a possible vaccine for HIV.  The effort to develop such a vaccine should be given high priority.
    "This is another example of how research using animals is necessary to develop treatments for illnesses.  In this instance, scientists using animals in their research have uncovered an important clue to the design of a vaccine effective against HIV.  The deadly AIDS disease has already killed tens of thousands of people worldwide.  These published findings should help in the race against AIDS.
    "Biomedical research has dramatically improved the quality and expected length of life of every person in society.  The vast majority of Americans -- over 75 percent -- are keenly aware of the necessity of using animals for future progress in medicine.  The medical community overwhelmingly agrees that without animal research the fight against Alzheimer's, cancer, heart disease, stroke, multiple sclerosis and hundreds of other major health threats will be markedly compromised, if not completely lost."
    -0-          2/21/92
    /CONTACT:  Paul Tarini of AMA, 312-464-5945/ CO:  American Medical Association ST:  Illinois IN:  HEA SU: SH -- NY015 -- 1330 02/21/92 10:50 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 21, 1992
Words:226
Previous Article:HOLOPAK TECHNOLOGIES NAMES DAVID W. JAFFIN CHIEF FINANCIAL OFFICER
Next Article:KROGER FILES SHELF REGISTRATION
Topics:


Related Articles
THERION BIOLOGICS RECEIVES $5.0 MIL. GRANT FROM NIAID TO EXPAND AIDS VACCINE DEVELOPMENT PROGRAM; HARVARD LICENSEE RECEIVES $6.0 MIL. GRANT
The Politics of AIDS Vaccines In the Developing World.
Chiron Awarded NIH Contract to Develop HIV Vaccine.
Phase II Results Show Significant Increase in CD4 Counts Without Producing A Sustained Increase in Viral Load Levels in HIV-Infected Patients...
PHASE II RESULTS SHOW SIGNIFICANT INCREASE IN CD4 COUNTS WITHOUT PRODUCING A SUSTAINED INCREASE IN VIRAL LOAD LEVELS IN HIV-INFECTED PATIENTS...
Fred Hutchinson Cancer Research Center/University of Washington HIV Vaccine Trials Unit to Open Its Doors in Celebration of HIV Vaccine Awareness Day.
Fourth Annual HIV Vaccine Awareness Day Honors Volunteers for Their Selfless Contribution to HIV Research.
VaxGen's AIDS Vaccine for Developing World Shows Unexpected Activity.
ImmunoVaccine Technologies Partners With FIT Biotech to Advance a Therapeutic HIV Vaccine.
Encouraging HIV/AIDS vaccine trial results support GeoVax strategy.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters